Who Ultima Hires
Ultima Genomics splits its hiring between the people who install and tend its sequencers in the field and the people who build and test them in Fremont. This guide maps the complete hiring picture — who gets hired, what roles pay, the interview stages candidates must pass, where work happens, and the traits that predict success, so candidates can decide whether to apply and how to prepare.
The company's live postings on Zero G Talent show six active roles: two field service engineers at different levels, a senior field application scientist, two technician tracks in sequencing and production, and an HR coordinator. That mix reveals where the operational weight sits.
The field roles form the company's external face. A Field Service Engineer I in a development program and a Field Service Engineer II in Phoenix signal a tiered support structure: early-career engineers rotating through structured training, and veterans owning regional territories. The Senior Field Application Scientist, listed as remote anywhere in the U.S., bridges sales and engineering: the person who shows a core facility director how to coax publishable data from the instrument. These are deployment hires, not pure research roles.
Inside Fremont, the two Technician I positions, Sequencing and Production, set the manufacturing rhythm. Sequencing technicians run instruments, prep libraries, and generate the data that validates each build. Production technicians assemble the fluidic and optical subsystems that make the chemistry work. Both list $25 an hour, matching entry-level biomanufacturing rates in the East Bay. The HR Coordinator at $28 an hour rounds out the operational backbone.
What's missing tells its own story: no software engineers, no bioinformaticians, no R&D scientists, no supply chain or quality leads. Those functions are either filled, contracted out, or recruited through channels not visible on this board. For a candidate, the gap is a signal: if your background is pure wet-lab R&D or cloud infrastructure, the open doors right now are in field deployment and manufacturing operations.
What the Roles Pay
Ultima's live listings cluster in a narrow band. Salaried positions span $52,000 to $71,000 with a $55,000 median.
| Role | Location | Type | Posted Band |
|---|---|---|---|
| Field Service Engineer I, Development Program | Fremont, CA | Hourly | $37/hr |
| HR Coordinator | Fremont, CA | Hourly | $28/hr |
| Technician I, Sequencing | Fremont, CA | Hourly | $25/hr |
| Technician I, Production | Fremont, CA | Hourly | $25/hr |
| Senior Field Application Scientist | Remote US | Salaried | Not posted |
| Field Service Engineer II | Phoenix, AZ | Salaried | Not posted |
The hourly rates translate to roughly $52,000–$77,000 annually at 40 hours a week with no overtime — overlapping the salaried band. The two roles without posted bands typically carry higher expectations. Ultima's silence on those figures means candidates must negotiate from market data, not the posting.
Four of six current listings are Fremont-based. The remote and Arizona roles show the company hires field-facing talent where customers sit, not just where the factory runs. That geographic split matters for cost-of-living calculations: a $55,000 median in Fremont buys less than the same number in Phoenix, and remote offers may index to a national benchmark rather than Bay Area rates.
The board shows only four salaried roles total. That small sample makes the $52k–$71k band a snapshot, not a structure. Early-stage hardware-bio companies often compress cash compensation and lean on equity upside; Ultima has raised over $700 million (according to Lightspeed Venture Partners) and the San Francisco Business Journal reported roughly $600 million raised by March 2023, suggesting runway for competitive grants, but the postings don't disclose them. Candidates should treat posted numbers as floors.
How the Interview Runs
Its careers page lists open roles and a generic apply flow but breaks down no stages, panel composition, or timeline expectations. What candidates can reconstruct comes from the roles themselves and from the operational profile leadership has described in interviews.
The open roles cluster in two buckets: field-deployed hardware and manufacturing roles (Field Service Engineers I and II, Technician I Sequencing, Technician I Production) and a smaller set of specialized scientific and coordination roles (Senior Field Application Scientist, HR Coordinator). All but the remote Field Application Scientist anchor at the Fremont headquarters or the Phoenix field territory. That concentration means most candidates will face at least one on-site step at the Fremont facility, which houses R&D, manufacturing, and the semiconductor-style wafer fabrication that defines Ultima's platform.
CEO Gilad Almogy has repeatedly framed the company's culture around semiconductor-industry discipline: long development cycles, precision at scale, zero tolerance for shortcuts. "We took a long-term view… we never got distracted to playing for short-term wins," he said in a 2023 interview. That mindset likely shapes how hiring managers evaluate candidates. A Field Service Engineer candidate who can describe debugging a vacuum deposition tool or a photolithography track in a cleanroom speaks the same language as the engineers who built the UG 100's open-flow cell on a silicon wafer. A Technician I applicant who has run shift-based production in a regulated environment (medical device, semiconductor, or high-volume biologics) maps directly to the "ultra-fast chemistry" and "billions of reads" throughput the platform promises.
The salary bands reinforce the split. That range matches early-commercialization biotech hardware companies in the Bay Area. Candidates should calibrate expectations: the compensation reflects a company that has raised over $700 million and is shipping product, but remains in "early access mode" per Almogy's 2022 BioSpace interview, optimizing with initial customers before broad commercial launch.
What disqualifies a candidate? The record doesn't spell it out, but the technology's pedigree offers a proxy. Ultima's core innovation — replacing the traditional flow cell with a semiconductor wafer, demands fluency in both life-sciences assay development and semiconductor process engineering. The strong application for Ultima right now is demonstrably hybrid: someone who has touched a wafer and a well plate.
The Senior Field Application Scientist role, listed as remote U.S., is the outlier. It signals Ultima is building a customer-facing scientific support layer. The company's partnerships (UK Biobank Pharma Proteomics, Chan Zuckerberg Institute's billion-cell sequencing, Arc Institute's virtual cell models) are the proof points a candidate should reference to show they understand where the platform sits in the BioAI ecosystem.
No public employee reviews detail a "culture fit" screen or values interview. But Almogy's own language ("relentlessly focused on our mission," "fast moving and nimble," "make decisions and act very quickly") functions as a de facto values statement. Candidates who frame their experience around shipping a complex instrument under regulatory pressure, or scaling a wet-lab protocol from bench to automation, will align.
The practical takeaway: apply to a specific requisition on the board, tailor the resume to the hybrid hardware-biology axis, and prepare for at least one on-site day in Fremont. The process isn't documented — but the work is.
Where the Work Lives
Ultima Genomics operates from a primary campus in Fremont, California, with a field-service footprint in Phoenix, Arizona, and a distributed team of field application scientists working remotely across the United States. The company's job postings on Zero G Talent make this geography concrete: every production, sequencing, and core engineering role listed in recent months sits in Fremont, while the sole Arizona posting is a Field Service Engineer II, and the role carries a "Remote US" designation.
Fremont is where the hardware gets built and the chemistry gets validated. The board lists four hourly roles tied to that site: Field Service Engineer I (Development Program) at $37/hour, HR Coordinator at $28/hour, Technician I Sequencing at $25/hour, and Technician I Production at $25/hour, and the mix tells you what the building contains. A "Development Program" field service engineer suggests a lab environment where prototype instruments are installed, stressed, and iterated before they ship. Technician I Sequencing implies a wet-lab or sequencing-floor operation where flow cells, reagents, and data pipelines are tested at scale. Technician I Production points to a manufacturing line assembling the instrument itself: optics, fluidics, thermal control, compute. The HR Coordinator at the same address confirms Fremont as the administrative center for Bay Area headcount.
The company's public history aligns with this layout. When Ultima emerged from stealth in June 2022, the San Jose Business Journal positioned it as a Bay Area startup targeting a $100 genome. By March 2023, that publication also noted a commercial release push for "next year" — meaning 2024. That timeline demands a facility that can transition from R&D to regulated manufacturing. Fremont's industrial zoning, supplier density, and talent pool from neighboring life-science and hardware companies make it the logical choice.
Phoenix appears as a service hub, not a build site. The Field Service Engineer II role there is salaried (no hourly band published) and carries a geography-specific title. Candidates should expect travel: field service at this stage means installing first-generation instruments at customer sites, troubleshooting hardware-software integration, and feeding failure modes back to Fremont engineering.
The previously mentioned remote role rounds out the model. Application scientists are the translational layer: they take the instrument from "it runs" to "it answers the customer's biological question." That work happens at the customer's bench, not Ultima's. A remote hire with a PhD and publication record in genomics can live near their collaborator network while flying to Fremont for quarterly alignment and to Phoenix for service coordination. The board shows no other remote roles, so this is a specialized exception, not a distributed-culture signal.
What the research doesn't show (and what candidates should ask) is whether Fremont houses a CLIA lab for internal validation runs, whether a second manufacturing line is planned for 2025, and whether the Phoenix office will add application scientists or remain service-only. The company's public statements emphasize a long-term, capital-intensive build (per Almogy's 2023 remark about avoiding short-term wins), so the physical footprint will likely expand in step with instrument placements. For now, the map is Fremont for build and core R&D, Phoenix for field service, and remote for high-level application support.
Who Lasts
The company's six-year stealth period, its semiconductor-borrowed architecture, and its current commercial pivot create a specific filter for who succeeds here. The evidence sits in the hiring record, the leadership appointments, and the technical roadmap the founders have described publicly.
Semiconductor Fluency Meets Biological Urgency
Ultima's core innovation — circular silicon wafers adapted from chip manufacturing that read DNA fragments in parallel, means the strongest contributors speak both languages. The MyHeritage collaboration announcement describes the wafers as "adapted from the semiconductor industry" acting as "the reaction surface on which millions of DNA fragments are read simultaneously." Shlomey Derhi, hired in 2023 as Head of Architecture and Integration, came from leading R&D for a large group within the Israel Defense Forces, a background that signals comfort with complex hardware systems under tight constraints. Mirna Jarosz, brought in as Head of Product Strategy the same month, ran Integrated DNA Technologies' NGS business. The pattern: people who have shipped instruments at scale, not just published papers about them.
Cost-and-Speed Obsession as Daily Operating Principle
The founder stated plainly in 2023: "all of our decisions throughout the history of the company have been driven by either driving the cost of sequencing down or the speed of sequencing up." That framing eliminates ambiguity. Candidates who thrive treat every design choice (polymerase engineering, base-calling models, wafer yield) through that lens. The team works on all these in parallel: longer reads, GC bias correction, insertion-deletion accuracy via machine learning, 99.9% accuracy demonstrations with new chemistry. Someone who needs a single clear spec to optimize against will struggle. The environment rewards engineers who can hold multiple competing knobs and articulate which turn moves the cost-per-genome needle most.
Stealth-to-Commercial Transition Tolerance
Ultima emerged from stealth in early 2022 with the UG100 headed for commercial launch. The 2023 leadership hires were explicitly "in preparation for commercial launch." The current board postings reflect that shift: Field Service Engineers in Fremont and Phoenix, a Senior Field Application Scientist (remote US), production and sequencing technicians. The company needs people who can operate in a factory that is still a development platform. The Sanger Institute's 2024 evaluation noted the UG100 "could dramatically reduce" per-genome cost to around $100 "at commercial launch" — present tense conditional. Employees who thrive treat "commercial" as a verb, not a milestone: they install instruments at customer sites (first installs happened in 2021), collect field data, and feed it back to the wafer process and base-calling pipeline.
Cross-Functional Collaboration Without Handoff Theater
The Trillion Gene Atlas project ("developed in collaboration with PacBio, Ultima Genomics, Anthropic, and NVIDIA") reveals the external-facing reality. Ultima sits at the intersection of sequencing hardware, cloud-scale compute, and foundation-model training. This role being remote-US while service engineers are site-tethered suggests a model where application expertise travels to customers but stays plugged into the Fremont core. People who succeed here document obsessively, communicate across time zones (Israel Defense Forces R&D leadership implies distributed-team experience), and treat customer data as the primary validation set — not an afterthought.
Iteration Velocity Over Perfectionism
The founder's 2023 talk showed 300-base reads with median error at 0.01% across the read length, then immediately listed the known gaps: polymerase improvements for longer reads, GC bias, indel accuracy, base-calling ML. "We're still working on obviously accuracy and read length but as a first shot we're pretty happy with it." That mindset — ship the first shot, instrument the hell out of it, iterate in public with customers, selects for engineers who prefer measurable progress on real hardware to theoretical optimality in simulation. The board's technician and field-service roles pay $25–37/hour in Fremont; these are not peripheral roles. They are the sensor network feeding the next wafer revision.
Background Signals From the Hiring Record
- Instrumentation engineers who have taken a novel assay from bench to manufactured product (Derhi's profile, the Field Service Engineer requirements)
- Commercial translators who map instrument capability to customer workflow (Jarosz's IDT background, the Field Application Scientist role)
- Data-loop closers who turn field sequencer output into chemistry and base-caller improvements (the ML-driven accuracy gains, the Trillion Gene Atlas partnership with Anthropic and NVIDIA)
The company's own description — "unleashing the power of genomics at scale" is not marketing fluff. It is the constraint that filters every hire. If your best work happens when the spec is frozen, the budget is fixed, and the customer is abstract, this is not your environment. If you want to turn semiconductor wafers into $100 genomes while the architecture is still growing knobs, the door is open.
Working in frontier tech? Zero G Talent tracks the openings: see every open Ultima Genomics role, browse frontier tech jobs, the companies hiring, and the people building the field.